[HTML][HTML] Resetting the transcription factor network reverses terminal chronic hepatic failure

T Nishikawa, A Bell, JM Brooks… - The Journal of …, 2015 - Am Soc Clin Investig
T Nishikawa, A Bell, JM Brooks, K Setoyama, M Melis, B Han, K Fukumitsu, K Handa, J Tian…
The Journal of clinical investigation, 2015Am Soc Clin Investig
The cause of organ failure is enigmatic for many degenerative diseases, including end-
stage liver disease. Here, using a CCl4-induced rat model of irreversible and fatal hepatic
failure, which also exhibits terminal changes in the extracellular matrix, we demonstrated
that chronic injury stably reprograms the critical balance of transcription factors and that
diseased and dedifferentiated cells can be returned to normal function by re-expression of
critical transcription factors, a process similar to the type of reprogramming that induces …
The cause of organ failure is enigmatic for many degenerative diseases, including end-stage liver disease. Here, using a CCl4-induced rat model of irreversible and fatal hepatic failure, which also exhibits terminal changes in the extracellular matrix, we demonstrated that chronic injury stably reprograms the critical balance of transcription factors and that diseased and dedifferentiated cells can be returned to normal function by re-expression of critical transcription factors, a process similar to the type of reprogramming that induces somatic cells to become pluripotent or to change their cell lineage. Forced re-expression of the transcription factor HNF4α induced expression of the other hepatocyte-expressed transcription factors; restored functionality in terminally diseased hepatocytes isolated from CCl4-treated rats; and rapidly reversed fatal liver failure in CCl4-treated animals by restoring diseased hepatocytes rather than replacing them with new hepatocytes or stem cells. Together, the results of our study indicate that disruption of the transcription factor network and cellular dedifferentiation likely mediate terminal liver failure and suggest reinstatement of this network has therapeutic potential for correcting organ failure without cell replacement.
The Journal of Clinical Investigation